EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Quantitative and simplified [18F] fluoroestradiol positron emission tomography (PET) measures of brain estrogen receptor expression

Matilde Nerattini iD, Valentina Berti, Dawn C Matthews, Schantel Williams, Caroline Andy, Francesca Fauci, Camila Boneu, Trisha Ajila, Silky Pahlajani, Michael Battista, Randolph Andrews, Alberto Pupi und 5 weitere

European Journal of Nuclear Medicine and Molecular Imaging · 2026-01 · 53 (2) · 1155-1168

DOI: 10.1007/s00259-025-07470-1 ↗

Kurz gefasst

Fachartikel in der Zeitschrift European Journal of Nuclear Medicine and Molecular Imaging, online erschienen am 07.08.2025. Verfasst von Matilde Nerattini und 16 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, Weill Cornell Medicine, New York, NY, USA. matilde.nerattini@unifi.it. Hauptthemen laut MEDLINE: Positron-Emission Tomography, Estradiol, Receptors, Estrogen, Brain. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 53 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Università degli Studi di Firenze.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Purpose

Positron emission tomography (PET) with 16α-[ 18 F]fluoro-17β-estradiol ( 18 F-FES) allows for the in vivo assessment of brain estrogen receptor (ER) expression. This study examines brain 18 F-FES uptake to define an optimal acquisition time for static late images suitable for clinical application.

Methods

Fifty-five healthy, 40–65-year-old women at different endocrine aging stages ( n = 18 premenopause, n = 18 perimenopause, and n = 19 postmenopause) underwent dynamic 90-minute 18 F-FES PET imaging. We obtained regional brain distribution volume ratios (DVR) based on Logan graphical analysis and standardized uptake value ratios (SUVR) at five 20 min increments (30–50, 40–60, 50–70, 60–80 and 70–90 min post-injection), using the cerebellar gray matter as the reference. We used reliability analysis and automated variable selection procedures to identify the most consistent SUVR time windows relative to DVR. In sensitivity analyses, we tested for group differences and associations with cognitive performance in these SUVR time frames. Analysis focused on the pituitary gland, which has demonstrated specific binding. Exploratory ER-rich regions of interest (ROI) included hypothalamus, hippocampus, amygdala, caudate, frontal and cingulate cortex.

Results

SUVR measurements exhibited stronger associations with DVR at earlier compared to later time frames. Specifically, the optimal SUVR time frames in pituitary, and in most exploratory ROIs, were predominantly within the 30–50 and 40–60 min intervals. Both intervals were effective at differentiating postmenopausal versus premenopausal groups, and the 30–50 min window showed more significant associations with cognitive scores.

Conclusions

Examination of quantitative and simplified methods for analysis of brain 18 F-FES PET uptake identified the 30–60 min SUVR window as performing optimally relative to DVR measures. This provides a practical method for quantifying relative pituitary tracer retention in clinical populations.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Positron-Emission TomographyEstradiolReceptors, EstrogenBrainHumansFemaleMiddle AgedAdultAged

Stichwörter der Autor:innen

BrainEstrogen receptorsFluoroestradiol (FES)Logan plotPositron Emission Tomography (PET)Women

Substanzen

EstradiolReceptors, Estrogen16-fluoroestradiol

Autor:innen und Institutionen

  • Department of Neurology, Weill Cornell Medicine, New York, NY, USA. matilde.nerattini@unifi.it.
  • Department of Biomedical Experimental and Clinical Sciences "Mario Serio", University of Florence, Viale Morgagni, 50, Florence, 50134, FI, Italy. matilde.nerattini@unifi.it.
  • Weill Cornell Neurology, 402 East 70th Street, New York, NY, 10021, USA. matilde.nerattini@unifi.it.
  • Department of Biomedical Experimental and Clinical Sciences "Mario Serio", University of Florence, Viale Morgagni, 50, Florence, 50134, FI, Italy.
  • ADM Diagnostics, Northbrook, IL, USA.
  • Department of Neurology, Weill Cornell Medicine, New York, NY, USA.

ORCID-Profile: Matilde Nerattini

Förderung

  • Università degli Studi di Firenze

Zitieren

APA

Nerattini, M., Berti, V., Matthews, D. C., Williams, S., Andy, C., Fauci, F., Boneu, C., Ajila, T., Pahlajani, S., Battista, M., Andrews, R., Pupi, A., Osborne, J. R., Fink, M., Brinton, R. D., Dyke, J. P., & Mosconi, L. (2026). Quantitative and simplified [18F] fluoroestradiol positron emission tomography (PET) measures of brain estrogen receptor expression. European Journal of Nuclear Medicine and Molecular Imaging, 53(2), 1155-1168. https://doi.org/10.1007/s00259-025-07470-1

Vancouver

Nerattini M, Berti V, Matthews DC, Williams S, Andy C, Fauci F, et al. Quantitative and simplified [18F] fluoroestradiol positron emission tomography (PET) measures of brain estrogen receptor expression. European Journal of Nuclear Medicine and Molecular Imaging. 2026;53(2):1155-1168. doi:10.1007/s00259-025-07470-1

BibTeX
@article{Nerattini2026,
  author = {Nerattini, Matilde and Berti, Valentina and Matthews, Dawn C and Williams, Schantel and Andy, Caroline and Fauci, Francesca and Boneu, Camila and Ajila, Trisha and Pahlajani, Silky and Battista, Michael and Andrews, Randolph and Pupi, Alberto and Osborne, Joseph R and Fink, Matthew and Brinton, Roberta Diaz and Dyke, Jonathan P and Mosconi, Lisa},
  title = {Quantitative and simplified [18F] fluoroestradiol positron emission tomography (PET) measures of brain estrogen receptor expression},
  journal = {European Journal of Nuclear Medicine and Molecular Imaging},
  year = {2026},
  volume = {53},
  number = {2},
  pages = {1155--1168},
  doi = {10.1007/s00259-025-07470-1}
}
Kostenlos starten →